EntryPoint Capital, LLC LAB — STANDARD BIOTOOLS INC

Ownership history in EntryPoint Capital, LLC  ·  4 quarters on record

AI Ownership Summary

EntryPoint Capital, LLC reported STANDARD BIOTOOLS INC (LAB) in 4 quarterly 13F filings from 2024 Q3 through 2026 Q2. Peak portfolio weight reached 0.13% in 2025 Q1. The latest visible filing shows LAB at 0.04% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this LAB ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was EntryPoint Capital, LLC's position in STANDARD BIOTOOLS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

LAB was reported at 0.04% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.13% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

LAB stock page EntryPoint Capital, LLC fund profile EntryPoint Capital, LLC full holdings
How EntryPoint Capital, LLC held LAB — position size vs. price
% of Fund (quarterly)    LAB price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 4 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED — — — 34,374 +9,767 +39.7% 0.04% $61K 2026-08-13 $0.75
2025 Q4 REDUCED 90.3% -28.1% ✅ 24,607 -229,061 -90.3% 0.01% $31K 2026-02-12 $1.11
2025 Q1 ADDED — — — 253,668 +139,801 +122.8% 0.13% $274K 2025-05-14 $1.07
2024 Q3 INITIATED — — — 113,867 — — 0.13% $220K 2024-11-13 $1.84

🏢 Other funds also holding LAB

As of 2026 Q2 — sorted by position size

Casdin Capital, LLC 3Y 7Y 3.66% MAK CAPITAL ONE LLC 3Y 7Y 3.32% Peapod Lane Capital LLC 1.34% Hollow Brook Wealth Management LLC 3Y 7Y 0.9% Tikvah Management LLC 3Y 7Y 0.89% Mink Brook Asset Management LLC 0.8% Long Focus Capital Management, LLC 3Y 0.49% QVIDTVM Management LLC 3Y 0.24% VIKING GLOBAL INVESTORS LP 3Y 7Y 0.14% Sone Capital Management, LLC 0.13%

FAQ About EntryPoint Capital, LLC and LAB

These are the practical questions this page is built to answer before you even open the full history table.

How long has EntryPoint Capital, LLC reported owning LAB?

EntryPoint Capital, LLC reported LAB across 4 quarterly 13F filings, from 2024 Q3 through 2026 Q2.

What was the largest reported LAB position in EntryPoint Capital, LLC's portfolio?

The largest reported portfolio weight for LAB was 0.13% in 2025 Q1.

What is the latest reported LAB position on this page?

The most recent filing on this page is 2026 Q2, when EntryPoint Capital, LLC reported 34,374 shares, equal to 0.04% of portfolio, with an estimated market value of $61K.

What does the chart on this LAB ownership page compare?

The chart compares EntryPoint Capital, LLC's quarterly LAB portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did EntryPoint Capital, LLC time their LAB position?

Based on 13F filing dates vs. subsequent LAB price moves, EntryPoint Capital, LLC correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on LAB relative to SPY over the holding period was +654.7%.

← Back to EntryPoint Capital, LLC Holdings